Ligand Pharmaceuticals Inc.

NAS: LGND

GO
/marketstate/country/us

Market open

/zigman2/quotes/202030140/composite

$

122.61

Change

+0.33 +0.27%

Volume

Volume 171,530

Jan 15, 2021, 1:20 p.m.

Real time quotes

/zigman2/quotes/202030140/composite

Previous close

$ 122.28

$ 122.61

Change

+0.33 +0.27%

Day low

Day high

$121.00

$126.00

Open
Open: 122.01

52 week low

52 week high

$57.24

$127.80

Open

Market cap

$1.97B

Average volume

312,159

P/E ratio

N/A

Rev. per Employee

$1.05M

EPS

-0.98

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lgnd

MarketWatch News on LGND

  1. 20 best mid-cap stocks for 2021, according to analysts

    7:31 a.m. Dec. 28, 2020

    - Philip van Doorn

  2. Landec and Evolent Health See Activist Action

    8:30 p.m. Aug. 28, 2020

    - Barron's Online

  3. Ligand Pharmaceuticals stock price target raised to $155 from $135 at Benchmark

    5:05 a.m. July 14, 2020

    - Tomi Kilgore

  4. Strategists Pick Winning Stocks for a Volatile Market

    11:43 a.m. June 12, 2020

    - Barron's Online

  5. Hedge Fund Alleges SEC Bias in Short-Selling Case

    6:30 a.m. Feb. 19, 2020

    - Barron's Online

  6. Ligand Pharmaceuticals started at buy with $135 stock price target at Benchmark

    8:25 a.m. Feb. 6, 2020

    - Tomi Kilgore

  7. Top stock picks for 2020: Making money with midsize firms

    10:41 p.m. Dec. 12, 2019

    - Philip van Doorn

  8. Ligand Pharmaceuticals sets new $500 mln stock repurchase program

    5:32 a.m. Sept. 12, 2019

    - Tomi Kilgore

  9. Like Amazon, these stocks have 100% buy ratings from analysts

    6:24 a.m. April 25, 2019

    - Philip van Doorn

  10. Ligand Pharma shares slide 17% after short seller Citron says pipeline is a 'pipe dream'

    1:00 p.m. Jan. 16, 2019

    - Ciara Linnane

  11. These are the top stock picks for 2019 among Wall Street analysts

    7:21 a.m. Jan. 4, 2019

    - Philip van Doorn

  12. Tesla CEO Elon Musk Is Wrong About Short Sellers

    10:32 a.m. Oct. 16, 2018

    - Barron's Online

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/lgnd

Other News on LGND

  1. Ligand receives milestone payment from Merck

    9:16 a.m. Jan. 13, 2021

    - Seeking Alpha

  2. Ligand Pharma (LGND) Receives a Rating Update from a Top Analyst

    11:01 a.m. Dec. 22, 2020

    - SmarterAnalyst

  3. Primecap Management Dissolves Pfenex Holding, Boosts Biogen

    2:31 p.m. Dec. 11, 2020

    - GuruFocus.com

  4. AbCellera Biologics Proposes $357 Million IPO Terms

    7:13 p.m. Dec. 7, 2020

    - Seeking Alpha

  5. Seeking Alpha Catalyst Watch

    3:30 p.m. Dec. 4, 2020

    - Seeking Alpha

  6. Ligand: Scalable Growth

    7:23 a.m. Dec. 4, 2020

    - Seeking Alpha

  7. 10-Q: LIGAND PHARMACEUTICALS INC

    4:28 p.m. Nov. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. Ligand (LGND) Q3 Earnings & Sales Fall Short of Estimates

    11:06 a.m. Nov. 2, 2020

    - Zacks.com

  9. Ligand Pharmaceuticals Q3 2020 Earnings Preview

    12:49 p.m. Oct. 29, 2020

    - Seeking Alpha

  10. What's in Store for Ligand (LGND) This Earnings Season?

    12:00 p.m. Oct. 28, 2020

    - Zacks.com

  11. 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

    2:05 p.m. Oct. 23, 2020

    - InvestorPlace.com

  12. Loading more headlines...
/news/pressrelease/company/us/lgnd

Press Releases on LGND

  1. Ligand Receives Milestone Payment from Merck

    8:30 a.m. Jan. 13, 2021

    - BusinessWire - BZX

  2. Ligand Reports Third Quarter 2020 Financial Results

    7:00 a.m. Oct. 30, 2020

    - BusinessWire - BZX

  3. Ligand Pharmaceuticals, Inc. to Host Earnings Call

    5:45 a.m. Oct. 30, 2020

    - ACCESSWIRE

  4. Ligand Provides Highlights from Today’s Investor Day Event

    1:05 p.m. Oct. 20, 2020

    - BusinessWire - BZX

  5. Ligand’s Third Quarter Financial Results to be Reported October 30th

    3:02 p.m. Oct. 19, 2020

    - BusinessWire - BZX

  6. Ligand to Divest Vernalis Research Operations

    8:00 a.m. Oct. 12, 2020

    - BusinessWire - BZX

  7. HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery

    5:24 a.m. Oct. 12, 2020

    - BusinessWire - BZX

  8. Ligand to Host Virtual Investor Day on October 20th

    7:00 a.m. Oct. 2, 2020

    - BusinessWire - BZX

  9. Ligand Completes Acquisition of Pfenex Inc.

    7:24 a.m. Oct. 1, 2020

    - BusinessWire - BZX

  10. Loading more headlines...

Rates »

Link to MarketWatch's Slice.